CLINICAL_TRIALS
trial_result
· 2023-10-23
Clinical Trial Update: A Study to Assess the Efficacy and Safety of Tanfanercept (HL036) Ophthalmic Solution in Participants With Dry Eye [Phase 3]
Summary
Phase 3 trial completed evaluating the efficacy and safety of Tanfanercept (HL036) ophthalmic solution for dry eye disease; results posted in 2023.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: HanAll BioPharma Co., Ltd. | Conditions: Dry Eye | Phase 3 | Status: COMPLETED | Results posted: 2023-10-23